These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Eleopra R, Tugnoli V, Rossetto O, De Grandis D, Montecucco C. Neurosci Lett; 1998 Nov 13; 256(3):135-8. PubMed ID: 9855358 [Abstract] [Full Text] [Related]
10. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6. Moritz MS, Tepp WH, Bradshaw M, Johnson EA, Pellett S. mSphere; 2018 Oct 24; 3(5):. PubMed ID: 30355669 [Abstract] [Full Text] [Related]
14. Comparison of oral toxicological properties of botulinum neurotoxin serotypes A and B. Cheng LW, Henderson TD. Toxicon; 2011 Jul 24; 58(1):62-7. PubMed ID: 21600236 [Abstract] [Full Text] [Related]
15. Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain. Zhang L, Lin WJ, Li S, Aoki KR. Gene; 2003 Oct 02; 315():21-32. PubMed ID: 14557061 [Abstract] [Full Text] [Related]
16. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain. Rani S, Ponmariappan S, Sharma A, Kamboj DV, Jain AK. Protein Pept Lett; 2017 Oct 02; 24(6):495-502. PubMed ID: 28260503 [Abstract] [Full Text] [Related]
17. A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo. Donald S, Elliott M, Gray B, Hornby F, Lewandowska A, Marlin S, Favre-Guilmard C, Périer C, Cornet S, Kalinichev M, Krupp J, Fonfria E. Pharmacol Res Perspect; 2018 Dec 02; 6(6):e00446. PubMed ID: 30519475 [Abstract] [Full Text] [Related]